Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
MicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was t...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2019-03-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428319826853 |
_version_ | 1818878526226432000 |
---|---|
author | Hikaru Nakashima Ryoji Yoshida Akiyuki Hirosue Kenta Kawahara Junki Sakata Hidetaka Arita Tatsuro Yamamoto Ryo Toya Ryuji Murakami Akimitsu Hiraki Masanori Shinohara Takaaki Ito Yoshikazu Kuwahara Hideki Nakayama |
author_facet | Hikaru Nakashima Ryoji Yoshida Akiyuki Hirosue Kenta Kawahara Junki Sakata Hidetaka Arita Tatsuro Yamamoto Ryo Toya Ryuji Murakami Akimitsu Hiraki Masanori Shinohara Takaaki Ito Yoshikazu Kuwahara Hideki Nakayama |
author_sort | Hikaru Nakashima |
collection | DOAJ |
description | MicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was to investigate the clinical significance of circulating microRNAs in oral squamous cell carcinoma patients. The expression levels of circulating miR-1246 and miR-1290 in healthy volunteers and oral squamous cell carcinoma patients were examined by quantitative real-time polymerase chain reaction. The expression levels of both microRNAs in the radioresistant oral squamous cell carcinoma cell line (SAS-R) and the parent cell line (SAS) and in the conditioned medium obtained from these cell lines were also examined by quantitative real-time polymerase chain reaction. In addition, the correlations between circulating microRNA status and various clinicopathological features in 55 oral squamous cell carcinoma patients with locally advanced oral squamous cell carcinoma who underwent surgery following 5-fluorouracil-based chemoradiotherapy were examined. The expression level of miR-1290 was significantly lower in the plasma of oral squamous cell carcinoma patients than in that of healthy volunteers (p < 0.01). The expression levels of microRNAs in the conditioned medium and in the cells varied from cell to cell. In the clinicopathological analyses, the frequency of patients with low miR-1290 levels was significantly higher among cases with lower pathological differentiation and among those with a poor pathological response for preoperative chemoradiotherapy (p = 0.030 each). Furthermore, Cox regression analysis based on the 5-year overall survival and disease-free survival revealed that miR-1290 status was a significant prognostic factor for patients with oral squamous cell carcinoma (hazard ratio = 0.169, p = 0.008, and hazard ratio = 0.186, p = 0.008, respectively). Circulating miR-1290 status could be a valuable biomarker for predicting the clinical response to chemoradiotherapy as well as overall survival in patients with oral squamous cell carcinoma. |
first_indexed | 2024-12-19T14:15:35Z |
format | Article |
id | doaj.art-0d9d8e1510a04e60ba36b47d03ec10a5 |
institution | Directory Open Access Journal |
issn | 1423-0380 |
language | English |
last_indexed | 2024-12-19T14:15:35Z |
publishDate | 2019-03-01 |
publisher | IOS Press |
record_format | Article |
series | Tumor Biology |
spelling | doaj.art-0d9d8e1510a04e60ba36b47d03ec10a52022-12-21T20:18:00ZengIOS PressTumor Biology1423-03802019-03-014110.1177/1010428319826853Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective studyHikaru Nakashima0Ryoji Yoshida1Akiyuki Hirosue2Kenta Kawahara3Junki Sakata4Hidetaka Arita5Tatsuro Yamamoto6Ryo Toya7Ryuji Murakami8Akimitsu Hiraki9Masanori Shinohara10Takaaki Ito11Yoshikazu Kuwahara12Hideki Nakayama13Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanDepartment of Radiation Oncology, Kumamoto University Hospital, Kumamoto, JapanDepartment of Medical Imaging, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanSection of Oral Oncology, Department of Oral and Maxillofacial Surgery, Fukuoka Dental College, Fukuoka, JapanItoh Dento-Maxillofacial Hospital, Kumamoto, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, JapanDivision of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanMicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression. However, their clinical value in patients with oral squamous cell carcinoma has not yet been fully explored. Therefore, the aim of this study was to investigate the clinical significance of circulating microRNAs in oral squamous cell carcinoma patients. The expression levels of circulating miR-1246 and miR-1290 in healthy volunteers and oral squamous cell carcinoma patients were examined by quantitative real-time polymerase chain reaction. The expression levels of both microRNAs in the radioresistant oral squamous cell carcinoma cell line (SAS-R) and the parent cell line (SAS) and in the conditioned medium obtained from these cell lines were also examined by quantitative real-time polymerase chain reaction. In addition, the correlations between circulating microRNA status and various clinicopathological features in 55 oral squamous cell carcinoma patients with locally advanced oral squamous cell carcinoma who underwent surgery following 5-fluorouracil-based chemoradiotherapy were examined. The expression level of miR-1290 was significantly lower in the plasma of oral squamous cell carcinoma patients than in that of healthy volunteers (p < 0.01). The expression levels of microRNAs in the conditioned medium and in the cells varied from cell to cell. In the clinicopathological analyses, the frequency of patients with low miR-1290 levels was significantly higher among cases with lower pathological differentiation and among those with a poor pathological response for preoperative chemoradiotherapy (p = 0.030 each). Furthermore, Cox regression analysis based on the 5-year overall survival and disease-free survival revealed that miR-1290 status was a significant prognostic factor for patients with oral squamous cell carcinoma (hazard ratio = 0.169, p = 0.008, and hazard ratio = 0.186, p = 0.008, respectively). Circulating miR-1290 status could be a valuable biomarker for predicting the clinical response to chemoradiotherapy as well as overall survival in patients with oral squamous cell carcinoma.https://doi.org/10.1177/1010428319826853 |
spellingShingle | Hikaru Nakashima Ryoji Yoshida Akiyuki Hirosue Kenta Kawahara Junki Sakata Hidetaka Arita Tatsuro Yamamoto Ryo Toya Ryuji Murakami Akimitsu Hiraki Masanori Shinohara Takaaki Ito Yoshikazu Kuwahara Hideki Nakayama Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study Tumor Biology |
title | Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study |
title_full | Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study |
title_fullStr | Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study |
title_full_unstemmed | Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study |
title_short | Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study |
title_sort | circulating mirna 1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma a single center retrospective study |
url | https://doi.org/10.1177/1010428319826853 |
work_keys_str_mv | AT hikarunakashima circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT ryojiyoshida circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT akiyukihirosue circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT kentakawahara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT junkisakata circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT hidetakaarita circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT tatsuroyamamoto circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT ryotoya circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT ryujimurakami circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT akimitsuhiraki circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT masanorishinohara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT takaakiito circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT yoshikazukuwahara circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy AT hidekinakayama circulatingmirna1290asapotentialbiomarkerforresponsetochemoradiotherapyandprognosisofpatientswithadvancedoralsquamouscellcarcinomaasinglecenterretrospectivestudy |